There’s an ahead-of-print article in Antimicrobial Agents and Chemotherapy whose authors include David Shlaes, a physician-researcher and former pharmaceutical executive, now consultant, and Brad Spellberg, an infectious disease physician on the UCLA medical faculty and author among other books of Rising Plague, about antibiotic resistance. In a commentary examining the Food and Drug Administration’s promised “reboot” of antibiotic development rules, they analyze privately gathered data on resistance in the United States and conclude the incidence of highly resistant bacteria is greater than the CDC has estimated.
More on 'Nightmare Bacteria': Maybe Even Worse Than We Thought?
Source: Wired Science
Art and Science of Laboratory Medicine
Facebook: www.facebook.com/LaboratoryEQASTwitter: LaboratoryEQAS